-->

Micky Show Digital Skills

micky show News and Digital Skills is a reputable website that presents current news and updates from leading world’s mass media. We are delivering and rendering legitimate services and keep you entertained always. Our content is not only interactive and outstanding but also makes an impact.

Welcome to MICKY SHOW NEWS AND DIGITAL SKILLS

Wednesday, 3 March 2021

2.3 million Nigerians have expressed interest in the new COVID-19 vaccine.

2.3 million Nigerians have expressed interest in the new COVID-19 vaccine. 
2.3 million Nigerians have expressed interest in the new COVID-19 vaccine.

The National Primary Health Care Development Agency (NPHCDA) on Wednesday dispelled concerns that people may not want to be vaccinated against the novel coronavirus, and pointed out that as many as 2.3 million Nigerians have expressed interest in vaccinating the needle.


Despite concerns about vaccine safety, NPHCDA Executive Director Faisal Shuaibu said Nigeria was enthusiastic about arriving at about 4 million AstraZeneca COVID needles on Monday.

2.3 million Nigerians have expressed interest in the new COVID-19 vaccine.

I can tell you that there is a lot of excitement. I know some people are worried about them, and we are working hard, but I want to give you an example of the enthusiasm of Nigerians who want to vaccinate these vaccines," the doctor said in an interview with the Daily Sunrise on Channel TV.


Around noon on Monday, when we launched the e-registration platform in less than 24 hours, we had as many as 2.3 million Nigerians registered. This number continues to increase.

2.3 million Nigerians have expressed interest in the new COVID-19 vaccine.

Although the arrival of the first vaccine has greatly contributed to Nigeria's fight against the disease of more than 150,000 people in the country, Dr. Faisal said that much remains to be done.


We therefore take this very seriously, which is why we will work very hard, he added. Yes, the vaccine is here, but more difficult work needs to be done to ensure that we provide vaccines to Nigerians in a respectful manner and without pressure.


He explained that the agency had developed a plan to launch a vaccine, which was only awaiting approval from the National Food and Drug Administration (NAFDAC).

2.3 million Nigerians have expressed interest in the new COVID-19 vaccine.

He said, "Well, we're waiting for NAFDAC." We feel that they will do all the necessary tests, and once they give us a green light, we are ready to launch a vaccine.

NPHCDA bosses also refute rumors that vaccines have been distributed to high-level and powerful people in society, believing that front-line health workers and people exposed to the virus will take a priority in injection.


I'll tell you that we didn't distribute these vaccines to people in the rich or urban areas, absolutely not. Mr. President knows very well," continued Dr. Faisal.

2.3 million Nigerians have expressed interest in the new COVID-19 vaccine.

Mr. Vice President also added his voice, which was conveyed by the Chairman of the Presidential Task Force in the media briefing of the Presidential Task Force. He made it very clear who we would give priority, and I would reiterate here again that the first people who would be vaccinated were those who had died in the past year, and they took care of all Nigerians infected with novel coronavirus pneumonia. So front-line health workers.


On Friday, we will launch a vaccine, and we will launch a vaccine at the treatment center of the national hospital. Our priority will be front-line health workers. We'll give these vaccines to emergency personnel.


In addition to health workers, he pointed out that some leaders will be vaccinated. He said it would persuade more Nigerians to shoot.


The head of the U.S. National Drug Administration said: "We will pay attention to strategic leaders such as Mr. President and Vice Presidents, who also want to be publicly vaccinated so that they can inspire followers to vaccinate and convince them that the vaccine is very safe."

No comments:

Popular posts

Labels

Please Follow us here